156 related articles for article (PubMed ID: 23506951)
1. Detection of circulating tumor cells in breast cancer with a refined immunomagnetic nanoparticle enriched assay and nested-RT-PCR.
Li FR; Li Q; Zhou HX; Qi H; Deng CY
Nanomedicine; 2013 Oct; 9(7):1106-13. PubMed ID: 23506951
[TBL] [Abstract][Full Text] [Related]
2. Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay.
Li Q; Qi H; Zhou HX; Deng CY; Zhu H; Li JF; Wang XL; Li FR
Int J Nanomedicine; 2011; 6():2175-81. PubMed ID: 22114481
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
[TBL] [Abstract][Full Text] [Related]
5. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
[TBL] [Abstract][Full Text] [Related]
6. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
Bonmassar L; Fossile E; Scoppola A; Graziani G; Prete SP; Formica V; Cappelletti D; De Vecchis L; Cardillo A; Concolino F; D'Atri S; Balduzzi A; Torino F; Caporaso P; Greiner JW; Bonmassar E; Roselli M; Aquino A
Anticancer Res; 2010 Nov; 30(11):4721-30. PubMed ID: 21115931
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of peripheral blood double detection of CK19 and MUC1 mRNA positive cells detected by RT-quantitative PCR in 94 breast cancer patients with a follow up of 9 years.
Pierga JY; Bidard FC; Denis MG; de Cremoux P
Mol Oncol; 2007 Dec; 1(3):267-8. PubMed ID: 19383302
[No Abstract] [Full Text] [Related]
9. Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer.
Strati A; Kasimir-Bauer S; Markou A; Parisi C; Lianidou ES
Breast Cancer Res; 2013 Mar; 15(2):R20. PubMed ID: 23497487
[TBL] [Abstract][Full Text] [Related]
10. Real-time quantitative PCR detection of circulating tumor cells using tag DNA mediated signal amplification strategy.
Mei T; Lu X; Sun N; Li X; Chen J; Liang M; Zhou X; Fang Z
J Pharm Biomed Anal; 2018 Sep; 158():204-208. PubMed ID: 29885605
[TBL] [Abstract][Full Text] [Related]
11. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19.
Zhong XY; Kaul S; Lin YS; Eichler A; Bastert G
J Cancer Res Clin Oncol; 2000 Apr; 126(4):212-8. PubMed ID: 10782894
[TBL] [Abstract][Full Text] [Related]
12. Biomimetic immunomagnetic gold hybrid nanoparticles coupled with inductively coupled plasma mass spectrometry for the detection of circulating tumor cells.
Chang ZM; Zhou H; Yang C; Zhang R; You Q; Yan R; Li L; Ge M; Tang Y; Dong WF; Wang Z
J Mater Chem B; 2020 Jun; 8(23):5019-5025. PubMed ID: 32393955
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
14. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
Park HS; Han HJ; Lee S; Kim GM; Park S; Choi YA; Lee JD; Kim GM; Sohn J; Kim SI
Yonsei Med J; 2017 Jan; 58(1):19-26. PubMed ID: 27873491
[TBL] [Abstract][Full Text] [Related]
15. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies.
Antolovic D; Galindo L; Carstens A; Rahbari N; Büchler MW; Weitz J; Koch M
BMC Biotechnol; 2010 Apr; 10():35. PubMed ID: 20426872
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy.
Nunes RA; Li X; Kang SP; Burstein H; Roberts L; Carney W; Blackwell K; Ryan P; Borges V; Iglehart JD; Friedman P; Harris LN
Int J Biol Markers; 2009; 24(1):1-10. PubMed ID: 19404916
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
[TBL] [Abstract][Full Text] [Related]
19. Immunomagnetic Capture and Multiplexed Surface Marker Detection of Circulating Tumor Cells with Magnetic Multicolor Surface-Enhanced Raman Scattering Nanotags.
Wilson RE; O'Connor R; Gallops CE; Kwizera EA; Noroozi B; Morshed BI; Wang Y; Huang X
ACS Appl Mater Interfaces; 2020 Oct; 12(42):47220-47232. PubMed ID: 32966038
[TBL] [Abstract][Full Text] [Related]
20. Immunomagnetic antibody plus aptamer pseudo-DNA nanocatenane followed by rolling circle amplication for highly-sensitive CTC detection.
Wang J; Dong HY; Zhou Y; Han LY; Zhang T; Lin M; Wang C; Xu H; Wu ZS; Jia L
Biosens Bioelectron; 2018 Dec; 122():239-246. PubMed ID: 30267982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
